Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data from the study of SARS-CoV and other respiratory viruses suggest thatanti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and …

Legal Symposium II

This month’s Legal Symposium features attorneys in the legal specialties of Workman’s Compensation, Employment Law (EEOC), False Claims Act, and Criminal Suits discussing avenues for legal help for those subjected to the unlawful mandates for unlicensed, experimental EUA medical products during the COVID pandemic: “vaccines,” …